SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-037671
Filing Date
2017-10-04
Accepted
2017-10-04 17:58:40
Documents
1
Period of Report
2017-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5062
  Complete submission text file 0001140361-17-037671.txt   6621
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address
Paulson John (Reporting) CIK: 0001394923 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 171122782